Hikma Pharmaceutical reported 960M in Current Liabilities for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
AstraZeneca AZN:LN 22222M 709M
Bayer BAYN:GR € 27926M 1006M
Fresenius FRE:GR € 15204M 743M
Fresenius Medical Care FMS:US $ 7425M 182.03M
Galapagos GLPG:NA € 576.98M 28.38M
Genmab GEN:DC DK 1351M 58M
GlaxoSmithKline GSK:LN 21387M 1112M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 8.44B 474M
Hikma Pharmaceutical HIK:LN 960M 68M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9820M 832M
Orion ORNBV:FH € 179.8M 218.5M
Recordati REC:IM € 586.37M 42.24M